Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Overview
publication date
- July 1, 2007
published in
Research
keywords
- Antibodies, Anti-Idiotypic
- Fallopian Tube Neoplasms
- Ovarian Neoplasms
- Peritoneal Neoplasms
Identity
Scopus Document Identifier
- 34447117547
Digital Object Identifier (DOI)
- 10.1158/1078-0432.CCR-06-2664
PubMed ID
- 17606738
Additional Document Info
volume
- 13
issue
- 13